Biocon posts Q4 FY24 PAT at Rs. 135 Cr
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Highly effective preservation solutions ensuring the safety and protection of personal care products
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
Subscribe To Our Newsletter & Stay Updated